JPH09103275A - Tablet confection containing galenical extract-compounded microcapsule - Google Patents

Tablet confection containing galenical extract-compounded microcapsule

Info

Publication number
JPH09103275A
JPH09103275A JP7287894A JP28789495A JPH09103275A JP H09103275 A JPH09103275 A JP H09103275A JP 7287894 A JP7287894 A JP 7287894A JP 28789495 A JP28789495 A JP 28789495A JP H09103275 A JPH09103275 A JP H09103275A
Authority
JP
Japan
Prior art keywords
extract
microcapsules
galenical
microcapsule
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP7287894A
Other languages
Japanese (ja)
Inventor
Takahisa Nakano
隆久 仲野
Katsuhiro Ushifusa
勝弘 牛房
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riken Vitamin Co Ltd
Original Assignee
Riken Vitamin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken Vitamin Co Ltd filed Critical Riken Vitamin Co Ltd
Priority to JP7287894A priority Critical patent/JPH09103275A/en
Publication of JPH09103275A publication Critical patent/JPH09103275A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Formation And Processing Of Food Products (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject tablet containing a galenical extract whose medicinal effect can be expected, excellent in portability, capable of being always eaten, useful for maintaining health, and good in flavor by adding galenical extract-compounded microcapsules to a food raw material and subsequently tableting the mixture. SOLUTION: Panax ginseng extract, Ginko biloba leaf extract, Crataegus cuneata extract, Glycyrrhiza glabra extract, Euphoria longana extract, etc., as a galenical extract is mixed with gelatin, xanthane gum, locust bean gum, etc., in water. The mixture is further mixed with sugar, etc., and dissolved at 70 deg.C. The solution is transferred to a particle-forming tower with a metering pump, and sprayed in air from the overhead of the tower with a rotary disk type atomizer to produce 700-1000μm liquid drops, which are cooled to a material temperature. The solidified products are dried to obtain the galenical extract-containing microcapsules. The microcapsules are mixed with a food raw material and subsequently tableted to obtain the objective tablets excellent in portability, capable of being always eaten, and useful as a health food, etc.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、生薬エキスを配合
したマイクロカプセルを含有してなる風味の良好な錠菓
に関する。
TECHNICAL FIELD The present invention relates to a tablet confectionery containing a microcapsule containing a crude drug extract and having a good flavor.

【0002】[0002]

【従来の技術】従来から各種生薬及びその抽出物やビタ
ミン類を配合し、滋養強壮や疲労回復などを追求したド
リンク剤が多種市販されている。しかしこれらのドリン
ク剤は疲れを感じる会議中や通勤電車などの移動中に手
軽に摂取することが、飲料(液体)であるがゆえに困難
である。また携帯性に劣ることや、冷却しないと風味上
飲みにくいなど使用上の制約を受けざるを得ない面もあ
る。また、簡便性から生薬エキスをマイクロカプセル中
に配合したものも市販されているものの、口臭予防や爽
快感を期待するものであり、食品としてのおいしさを期
待するものではない。薬効の期待できる生薬エキスを含
有し、携帯性に優れ、いつでも食することのできる風味
の良い錠菓は未だ市販されていない。
2. Description of the Related Art Conventionally, various kinds of drinks containing various crude drugs, their extracts and vitamins and pursuing nourishing tonic and recovery from fatigue have been commercially available. However, it is difficult to take these drinks easily because they are beverages (liquids) during a tired meeting or while traveling on a commuter train. In addition, it is inferior in portability, and it is inevitable that it will be difficult to drink unless it is cooled, which makes it difficult to drink. In addition, although a medicinal herb extract mixed in a microcapsule is commercially available due to its simplicity, it is expected to prevent bad breath and feel refreshed, and is not expected to be delicious as a food. A tablet confection containing a crude drug extract that is expected to have a medicinal effect, excellent portability, and a flavor that can be eaten at any time has not yet been marketed.

【0003】[0003]

【発明が解決しようとする課題】そこで本発明は、薬効
の期待できる生薬エキスをマイクロカプセルとして含有
し、携帯性に優れ、いつでも食することのできる風味の
良い錠菓を提供することを目的とする。
SUMMARY OF THE INVENTION Therefore, an object of the present invention is to provide a tablet confection containing a herbal medicine extract, which is expected to have a medicinal effect, as a microcapsule, which has excellent portability and can be eaten at any time. To do.

【0004】[0004]

【課題を解決するための手段】本発明の上記目的は、
1.生薬エキスを配合したマイクロカプセルを含有する
錠菓、2.錠菓中のマイクロカプセル含量が2〜30重
量%である請求項1記載の錠菓、3.マイクロカプセル
中の生薬エキス含有量が2〜75重量%である請求項1
又は2記載の錠菓、によって達成される。
The above objects of the present invention are as follows.
1. 1. Tablet confectionery containing microcapsules containing a crude drug extract. 2. The tablet confectionery according to claim 1, wherein the microcapsule content in the tablet confectionery is 2 to 30% by weight. The content of the crude drug extract in the microcapsules is 2 to 75% by weight.
Alternatively, it is achieved by the tablet confectionery described in 2.

【0005】[0005]

【発明の実施の形態】一般に生薬エキスは独特の臭いや
苦みを持つものが多く、各種の薬効があると云われてい
るものでも、その臭いや苦みが最終製品に残りやすいた
めに食品原料としての使用が制限されることがある。
BEST MODE FOR CARRYING OUT THE INVENTION Generally, many herbal extracts have unique odors and bitterness, and even those which are said to have various medicinal effects, the odors and bitterness are likely to remain in the final product, so that they are used as food ingredients. The use of may be restricted.

【0006】例えば、イチョウ葉エキスは高血圧、動脈
硬化、老人性痴呆症などの予防や治療に効果があるとさ
れ、古くからヨーロッパでは健康維持に利用されてお
り、ドイツでは医薬品として使用されている。イチョウ
葉エキスは、フラボン配糖体やテルペン類を多く含むた
め強い苦みを有し、このために食品への展開が制限され
ている。
[0006] For example, ginkgo biloba extract is said to be effective in the prevention and treatment of hypertension, arteriosclerosis, senile dementia and the like, and has been used for a long time to maintain health in Europe and has been used as a drug in Germany. . Ginkgo biloba extract has a strong bitterness because it contains a large amount of flavone glycosides and terpenes, which limits its application to foods.

【0007】同様に、カノコソウは優れた鎮静作用を有
しているが、強い特有の臭いがあるために食品への適用
が困難である。
Similarly, valerian camphor has an excellent sedative effect, but it is difficult to apply it to foods because of its strong peculiar odor.

【0008】このような苦みや臭いを改善するために、
マイクロカプセル中に生薬エキスを封入することが考え
られるが、これだけの加工では臭いの改善は不充分であ
るし、またたとえ甘味料や酸味料を配合して苦みを改善
することを狙っても、矯味の端正にも不充分である。
In order to improve such bitterness and odor,
It is possible to enclose a crude drug extract in microcapsules, but the improvement of odor is not sufficient with just this processing, and even if a sweetener or an acidulant is blended, it is aimed to improve bitterness. The taste is not good enough.

【0009】そこで発明者らは、生薬エキスが配合され
たマイクロカプセルを他の食品素材と共に打錠し錠菓と
することで著しく矯味が端正されることを見いだし本発
明に至った。
Therefore, the present inventors have found that the taste is remarkably corrected by tableting the microcapsules containing the crude drug extract together with other food materials to form a tablet confectionery, and thus the present invention has been accomplished.

【0010】本発明で用いられる生薬エキス配合マイク
ロカプセルとともに打錠される食品素材は、砂糖、乳
糖、水飴、還元水飴、ブドウ糖、ソルビトール、マルチ
トール、パラチノース、エリスリトール、マンニトー
ル、ラクチトール、トレハロース、トレハルロース、キ
シリトール、澱粉、セルロースなどから選ばれる単独あ
るいは2以上組み合わせたものが挙げられるが、これら
に限定されるものではない。
The food materials to be tabletted together with the microcapsule containing crude drug extract used in the present invention are sugar, lactose, starch syrup, reduced starch syrup, glucose, sorbitol, maltitol, palatinose, erythritol, mannitol, lactitol, trehalose, trehalulose, Examples thereof include xylitol, starch, and cellulose, which may be used alone or in combination of two or more, but are not limited thereto.

【0011】本発明で用いられる生薬エキスとしては、
オタネニンジン、エゾウコギ、タイソウ、クコシ、イチ
ョウ、ヨモギ、リュウガンニク、カンゾウ、オウセイ、
サンソウニン、タイサン、サンザシ、カノコソウ、オウ
セイ、カミツレ、ガラナ、ジュウヤク、セイヨウサンザ
シから選ばれる単独あるいは2以上組み合わせたものが
挙げられるが、これらに限定されるものではない。
The crude drug extract used in the present invention includes:
Panax ginseng, eleuthero, pearl millet, kokushi, ginkgo, mugwort, longan garlic, licorice, prince,
Examples thereof include, but are not limited to, one or a combination of two or more selected from hawthorn nin, taisan, hawthorn, valerian, princese, chamomile, guarana, deer, hawthorn.

【0012】本発明中の錠菓に含まれるマイクロカプセ
ル含量は2〜30重量%であり、好ましくは5〜15重
量%である。30重量%より多い場合は錠菓が脆くなり
商品として不適であり、2重量%より少ない場合は薬効
が期待できない。
The microcapsule content contained in the tablet confectionery in the present invention is 2 to 30% by weight, preferably 5 to 15% by weight. If it is more than 30% by weight, the confectionery becomes brittle and unsuitable as a product. If it is less than 2% by weight, no medicinal effect can be expected.

【0013】本発明中の錠菓に含まれるマイクロカプセ
ル中の生薬エキスの含有量は2〜75重量%であり、7
5重量%を超えると良好なマイクロカプセルを製造する
ことが困難であり、2重量%より少ない場合はマイクロ
カプセルを錠菓中に多量に入れる必要があり、錠菓が脆
くなりやすい。また製品コスト上も不利である。
The content of the crude drug extract in the microcapsules contained in the tablet confectionery of the present invention is 2 to 75% by weight.
If it exceeds 5% by weight, it is difficult to produce good microcapsules, and if it is less than 2% by weight, it is necessary to put a large amount of microcapsules in the tablet confection, and the tablet confection tends to become brittle. It is also disadvantageous in terms of product cost.

【0014】その他、錠菓に一般的に配合される香料や
色素、滑択剤などは本発明に用いることができるし、味
付けの目的で果汁などを配合してもよい。また、本発明
にオリゴ糖、各種ビタミン、ミネラルなど併用配合して
錠菓とすることもできる。
In addition, flavors, pigments, lubricants and the like generally added to tablet confectionery can be used in the present invention, and fruit juice or the like may be added for the purpose of seasoning. Further, the present invention may be combined with an oligosaccharide, various vitamins, minerals and the like to prepare a tablet confection.

【0015】次に、マイクロカプセルについて説明す
る。マイクロカプセル化の方法には一般に(1)化学的
技法、(2)物理化学的技法、(3)物理的技法、
(4)その他等があり、その中で化学的技法は界面重合
法、液中硬化被覆法等に、物理化学的技法は水溶液系か
らの分離、有機溶媒系からの相分離法、液中乾燥法、融
解分散冷却法、粉床法等に、物理的技法は気中懸濁被覆
法、真空蒸着被覆法、噴霧乾燥法等に分類される。
Next, the microcapsules will be described. Microencapsulation methods generally include (1) chemical techniques, (2) physicochemical techniques, (3) physical techniques,
(4) Others, etc. Among them, chemical techniques include interfacial polymerization and in-liquid curing coating, and physicochemical techniques include separation from aqueous systems, phase separation from organic solvent systems, and in-liquid drying. The physical technique is classified into an air suspension coating method, a vacuum vapor deposition coating method, a spray drying method and the like.

【0016】この中でゼラチン等食用ゲル化剤を利用し
たマイクロカプセル製造法にはそのゲル化温度を応用し
た液中硬化法や、ゲル溶液での噴霧乾燥法、粉床法等の
組合せ技法等がある。
Among them, the microcapsule production method using an edible gelling agent such as gelatin is a combination method such as in-liquid hardening method applying the gelling temperature, spray drying method with gel solution, powder bed method, etc. There is.

【0017】本発明に用いるマイクロカプセルの好まし
い態様として次の技術が挙げられる。即ち、ゼラチン等
食用ゲル化剤を含むペースト液を噴霧微粒化後、冷却雰
囲気中にてゲル化点から凍結点まで品温を下げ補集後低
温乾燥することにより、すぐれた表面光沢を有し安定性
・味の良いマイクロカプセルを容易に得られる。
The following techniques can be mentioned as preferred embodiments of the microcapsules used in the present invention. That is, after spraying and atomizing a paste solution containing an edible gelling agent such as gelatin, the product temperature is lowered from the gelation point to the freezing point in a cooling atmosphere, and after collection and low-temperature drying, excellent surface gloss is obtained. Microcapsules with good stability and taste can be easily obtained.

【0018】本発明に用いるマイクロカプセルは食用ゲ
ル化剤で包み込んだ粒状物質が好ましい。さらに本発明
にいう食用ゲル化剤とは高分子構造を有した多糖類や蛋
白質があり、例えばペクチン、寒天、カラギーナン、ジ
ェランガム、ファーセレラン、アルギン酸、ゼラチン、
酵素分解レシチン、カゼイン等が挙げられるが、その種
類は何ら制限されるものではない。
The microcapsules used in the present invention are preferably granular substances wrapped with an edible gelling agent. Further, the edible gelling agent referred to in the present invention includes polysaccharides and proteins having a high molecular structure, for example, pectin, agar, carrageenan, gellan gum, furceleran, alginic acid, gelatin,
Examples thereof include enzyme-decomposed lecithin and casein, but the types thereof are not limited at all.

【0019】本発明でいう粉床法とは、食用ゲル化剤を
含むペースト液を微粒化噴霧後、取粉中で補集し、粒子
同志の付着凝集を防いだ後、分別してマイクロカプセル
を得る方法である。
The powder bed method referred to in the present invention means that a paste solution containing an edible gelling agent is atomized and sprayed and then collected during powdering to prevent the particles from adhering and agglomerating, and then being separated into microcapsules. Is the way to get.

【0020】本発明でいう噴霧乾燥法とは通常用いられ
ている乾燥法であり食用ゲル化剤を含むペースト液を熱
風中に微粒化噴霧し、粒子を乾燥してマイクロカプセル
を得る方法である。
The spray drying method in the present invention is a commonly used drying method and is a method in which a paste solution containing an edible gelling agent is atomized and sprayed in hot air and the particles are dried to obtain microcapsules. .

【0021】本発明でいう液中硬化法とは油脂等の分散
媒中で食用ゲル化剤を含むペースト液の微粒子を補集硬
化後、分散媒を分離除去することによりマイクロカプセ
ルを得る方法である。さらに液中攪拌硬化法とは食用ゲ
ル化剤を含むペースト液を分散媒中に流し込み攪拌分散
して微粒化硬化後、分散媒を分離除去することによりマ
イクロカプセルを得る方法である。
The submerged curing method referred to in the present invention is a method of obtaining microcapsules by collecting and curing fine particles of a paste liquid containing an edible gelling agent in a dispersion medium such as oil and fat, and then separating and removing the dispersion medium. is there. Further, the in-liquid agitation hardening method is a method in which a paste solution containing an edible gelling agent is poured into a dispersion medium, stirred and dispersed to be finely divided and hardened, and then the dispersion medium is separated and removed to obtain microcapsules.

【0022】本発明でいう乾燥とは補集されたマイクロ
カプセルのゲル化温度以下の冷風を通気して乾燥する方
法であり、具体的には流動乾燥装置の入風温度を対象乾
燥物のゲル化温度以下に保持するものであるが、乾燥装
置としては流動乾燥装置だけに制限されるものではな
い。
The term "drying" as used in the present invention means a method in which cold air below the gelling temperature of the collected microcapsules is aerated to dry the air. The drying device is not limited to the fluidized drying device, although the temperature is maintained below the oxidization temperature.

【0023】本発明でいう温域とは対象物質のゲル化温
度以上の雰囲気温度であり、冷域とはゲル化温度以下の
雰囲気温度である。この雰囲気を塔内に設けるには塔頂
部に温気発生装置を、塔底部に冷気発生装置を設け、塔
側面に排気孔を設ければ必然的に排気孔より上部は温域
となり、下部は冷域となる。
The temperature range referred to in the present invention is an ambient temperature above the gelation temperature of the target substance, and the cold region is an ambient temperature below the gelation temperature. To provide this atmosphere in the tower, a warm air generator is provided at the top of the tower, a cool air generator is provided at the bottom of the tower, and an exhaust hole is provided at the side surface of the tower. It becomes a cold area.

【0024】[0024]

【実施例】以下に実施例を示すが、本発明はこれに限定
されるものではない。
EXAMPLES Examples will be shown below, but the present invention is not limited to these examples.

【0025】実施例1 表1 マイクロカプセルの処方 ゼラチン 490g キサンタンガム 5g ローカストビーンガム 5g 砂糖 250g オタネニンジンエキス 50g イチョウ葉エキス 20g サンザシエキス 50g カンゾウエキス 80g リュウガンニクエキス 50g 水 1500g 表1に記載の配合比で70℃で溶解後、この溶液を定量
ポンプにより微粒化塔に送り、その塔頂から回転円盤式
のアトマイザーにより空気中に噴霧し、700〜100
0μmの液滴を生成させ、この液滴を落下中に品温0℃
まで冷却し固化させる。冷却粒子を捕集し流動乾燥装置
で乾燥し、生薬エキス配合マイクロカプセル800gを
得た。
Example 1 Table 1 Formulation of microcapsules Gelatin 490 g Xanthan gum 5 g Locust bean gum 5 g Sugar 250 g Panax ginseng extract 50 g Ginkgo biloba extract 20 g Hawthorn extract 50 g Licorice extract 80 g Longan garlic extract 50 g Water 1500 g In the mixing ratio shown in Table 1, 70 After dissolution at ℃, this solution was sent to the atomization tower by a metering pump, and sprayed into the air from the top of the tower by a rotary disk atomizer to 700-100
A droplet of 0 μm is generated, and the product temperature is 0 ° C while the droplet is falling.
Cool to solidify. The cooled particles were collected and dried by a fluidized drying device to obtain 800 g of microcapsule containing crude drug extract.

【0026】 表2 試験区1の配合 粉糖 50g ブドウ糖 38g 生薬カプセル(表1) 10g 粉末香料 1g 滑択剤 1g 表3 対照区1の配合 粉糖 52.5g ブドウ糖 38g オタネニンジンエキス 500mg イチョウ葉エキス 200mg サンザシエキス 500mg カンゾウエキス 800mg リュウガンニク 500mg ゼラチン 5g 粉末香料 1g 滑択剤 1g 表2の試験区1及び表3の対照区1に示す組成(重量
部)により打錠機を用いて打錠して製品とした。得られ
た製品を20名のパネラーに食させ、表4に従って評価
させた。その結果を表5に示した。
Table 2 Formulation of Test Group 1 Powdered sugar 50 g Glucose 38 g Crude drug capsule (Table 1) 10 g Powdered flavor 1 g Lubricating agent 1 g Table 3 Control group 1 combination Powdered sugar 52.5 g Glucose 38 g Panax ginseng extract 500 mg Ginkgo biloba extract 200 mg Hawthorn extract 500 mg Licorice extract 800 mg Longan garlic 500 mg Gelatin 5 g Powdered fragrance 1 g Lubricants 1 g Table 2 Test section 1 and Table 3 Control section 1 tableted using a tableting machine And The obtained product was eaten by 20 panelists and evaluated according to Table 4. Table 5 shows the results.

【0027】[0027]

【表4】 [Table 4]

【0028】[0028]

【表5】 実施例2 表6 マイクロカプセルの処方 ゼラチン 430g ジェランガム 10g キサンタンガム 10g ステビア 50g クエン酸 50g エゾウコギエキス 50g タイソウエキス 80g クコシエキス 80g オウセイエキス 80g オタネニンジンエキス 80g ビタミンB1 6g ビタミンB2 10g ビタミンB6 10g ナイアシン 34g カフェイン 20g 水 1500g 実施例1のマイクロカプセル製造と同様の操作により生
薬・ビタミン配合マイクロカプセル820gを得た。
[Table 5] Example 2 Table 6 Formulation of microcapsules Gelatin 430 g Gellan gum 10 g Xanthan gum 10 g Stevia 50 g Citric acid 50 g Eleuthero extract 50 g Thai soybean extract 80 g Kukoshi extract 80 g Ginseng extract 80 g Panax ginseng extract 80 g Vitamin B 1 6 g Vitamin B 6 A 10 g vitamin B 2 10 g Vitamin B 2 10 g 1,500 g of water By the same procedure as in the production of microcapsules of Example 1, 820 g of microcapsules containing crude drug and vitamins were obtained.

【0029】 表7 試験区2の配合 ソルビトール 80g エリスリトール 13g 生薬・ビタミンカプセル(表6) 5g 粉末香料 1g 滑択剤 1g 表8 対照区2の配合 ソルビトール 80g エリスリトール 13g エゾウコギエキス 250mg タイソウエキス 400mg クコシエキス 400mg オウセイエキス 400mg オタネニンジンエキス 400mg ビタミンB1 30mg ビタミンB2 50mg ビタミンB6 50mg ナイアシン 170mg カフェイン 100mg ステビア 250mg クエン酸 250mg ゼラチン 2.25g 粉末香料 1g 滑択剤 1g 表7の試験区2及び表8の対照区2に示す組成(重量
部)により打錠機を用いて打錠して製品とした。得られ
た製品を18名のパネラーに食させ、表4に従って評価
させた。その結果を表9に示した。
Table 7 Formulation of test group 2 Sorbitol 80 g Erythritol 13 g Crude drug / vitamin capsule (Table 6) 5 g Powdered flavor 1 g Lubricating agent 1 g Table 8 Formulation 2 of control group 2 Sorbitol 80 g Erythritol 13 g Eleuthero extract 250 mg Thai soybean extract 400 mg Ginger extract 400 mg 400 mg Panax ginseng extract 400 mg Vitamin B 1 30 mg Vitamin B 2 50 mg Vitamin B 6 50 mg Niacin 170 mg Caffeine 100 mg Stevia 250 mg Citric acid 250 mg Gelatin 2.25 g Powdered fragrance 1 g Lubricants 1 g Control group 2 in Table 7 and Table 8 The composition (parts by weight) shown in Table 1 was tableted using a tableting machine to give a product. The obtained product was eaten by 18 panelists and evaluated according to Table 4. Table 9 shows the results.

【0030】[0030]

【表9】 実施例2で得られた錠菓を18名のパネラーを2群分け
毎日10g(1g×10個)、7日間食させた後、以下
に示す症状に対して問診を行った。その改善度を被験者
に表10のように、評価を得点区分で点数をつけてもら
い、その平均点で疲労などの症状改善効果を評価した。
[Table 9] The tablet confectionery obtained in Example 2 was divided into two groups of 18 panelists and fed 10 g (1 g × 10 pieces) daily for 7 days, and then interviewed for the following symptoms. The degree of improvement was evaluated by the test subjects as shown in Table 10, and the effect of improving symptoms such as fatigue was evaluated based on the average score.

【0031】(症状改善) (a)疲労倦怠感、(b)息切れ、(c)頭痛、(d)
精力増進、(e)かたこり、(f)眼性疲労、(g)い
らいら、(h)耳鳴り、(i)食欲、(j)しびれ、
(k)顔色、(l)めまい、(m)不眠
(Amelioration of symptoms) (a) Fatigue, (b) shortness of breath, (c) headache, (d)
Energy enhancement, (e) stiffness, (f) eye fatigue, (g) irritability, (h) tinnitus, (i) appetite, (j) numbness,
(K) complexion, (l) dizziness, (m) insomnia

【0032】[0032]

【表10】 以上の問診結果は、表11にまとめた。本発明に従う実
施例2のマイクロカプセル含有錠菓の試験区2は、生薬
エキスを直接配合した対照区2と同様、疲労などの症状
改善効果を有することが実証された。
[Table 10] The results of the above interviews are summarized in Table 11. It was demonstrated that the test section 2 of the microcapsule-containing tablet confectionery of Example 2 according to the present invention has an effect of improving symptoms such as fatigue like the control section 2 in which the crude drug extract was directly blended.

【0033】[0033]

【表11】 [Table 11]

【0034】[0034]

【発明の効果】以上の通り、生薬エキスを配合したマイ
クロカプセルを含有する風味の良好かつ目的とする効果
を有する錠菓の開発に成功した。
As described above, the present invention has succeeded in developing a tablet confectionery containing microcapsules containing a crude drug extract, having a good flavor and a desired effect.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】生薬エキスを配合したマイクロカプセルを
含有する錠菓。
1. A tablet confectionery containing microcapsules containing a crude drug extract.
【請求項2】錠菓中のマイクロカプセル含量が2〜30
重量%である請求項1記載の錠菓。
2. The content of microcapsules in the tablet confectionery is 2 to 30.
The tablet confectionery according to claim 1, which is a weight%.
【請求項3】マイクロカプセル中の生薬エキス含有量が
2〜75重量%である請求項1又は2記載の錠菓。
3. The tablet confectionery according to claim 1 or 2, wherein the content of the crude drug extract in the microcapsules is 2 to 75% by weight.
JP7287894A 1995-10-09 1995-10-09 Tablet confection containing galenical extract-compounded microcapsule Withdrawn JPH09103275A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7287894A JPH09103275A (en) 1995-10-09 1995-10-09 Tablet confection containing galenical extract-compounded microcapsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7287894A JPH09103275A (en) 1995-10-09 1995-10-09 Tablet confection containing galenical extract-compounded microcapsule

Publications (1)

Publication Number Publication Date
JPH09103275A true JPH09103275A (en) 1997-04-22

Family

ID=17723100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7287894A Withdrawn JPH09103275A (en) 1995-10-09 1995-10-09 Tablet confection containing galenical extract-compounded microcapsule

Country Status (1)

Country Link
JP (1) JPH09103275A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003503433A (en) * 1999-07-02 2003-01-28 コグニス・イベリア・ソシエダッド・リミターダ Microcapsule-I
EP1454610A1 (en) * 2003-03-06 2004-09-08 Cognis France S.A. Cosmetic and/or pharmaceutical compositions comprising microencapsulated plant extracts
KR100526998B1 (en) * 2002-01-21 2005-11-08 임대우 Microcapsule containing red ginseng and ginseng extract powder for bitter taste masking
US8092826B2 (en) * 1997-08-14 2012-01-10 Kraft Foods Global Brands Llc Taste modified hard confectionery compositions containing functional ingredients
CN109619559A (en) * 2018-12-20 2019-04-16 丁传波 A kind of preparation method and production technology of fresh American ginseng buccal tablet
JP2022531889A (en) * 2019-05-06 2022-07-12 深▲セン▼臨屏晰睛視力技術有限公司 Herbal confectionery that protects the eyes and improves eyesight, containing nutrients for the crystalline lens and retinal photosensitive cells of the human eye.

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8092826B2 (en) * 1997-08-14 2012-01-10 Kraft Foods Global Brands Llc Taste modified hard confectionery compositions containing functional ingredients
JP2003503433A (en) * 1999-07-02 2003-01-28 コグニス・イベリア・ソシエダッド・リミターダ Microcapsule-I
JP4841091B2 (en) * 1999-07-02 2011-12-21 コグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Microcapsule-I
KR100526998B1 (en) * 2002-01-21 2005-11-08 임대우 Microcapsule containing red ginseng and ginseng extract powder for bitter taste masking
EP1454610A1 (en) * 2003-03-06 2004-09-08 Cognis France S.A. Cosmetic and/or pharmaceutical compositions comprising microencapsulated plant extracts
WO2004078149A1 (en) * 2003-03-06 2004-09-16 Cognis Ip Management Gmbh Cosmetic and/or pharmaceutical preparations containing micro-encapsulated plant extracts
CN109619559A (en) * 2018-12-20 2019-04-16 丁传波 A kind of preparation method and production technology of fresh American ginseng buccal tablet
JP2022531889A (en) * 2019-05-06 2022-07-12 深▲セン▼臨屏晰睛視力技術有限公司 Herbal confectionery that protects the eyes and improves eyesight, containing nutrients for the crystalline lens and retinal photosensitive cells of the human eye.

Similar Documents

Publication Publication Date Title
Sarabandi et al. Application of gum Arabic and maltodextrin for encapsulation of eggplant peel extract as a natural antioxidant and color source
CN101448408B (en) One step spray-drying process
Mudalip et al. A short review on encapsulation of bioactive compounds using different drying techniques
US8119173B2 (en) Method of flavor encapsulation through the use of a drum coater
CN107072239A (en) Chewable product and methods for making them
WO1997016078A1 (en) Aromatic granulated material
JP4025578B2 (en) Slimming food
WO2010139987A2 (en) Mesoporous materials
KR20060090894A (en) Method of preparing the granular green tea powder
WO2012122010A2 (en) Spray-dried compositions capable of retaining volatile compounds and methods of producing the same
JP3611652B2 (en) Manufacturing method of coating powder
CN101652074A (en) confectionery products comprising polyols
JPH06254382A (en) Production of microcapsule and its apparatus for production
WO2014188861A1 (en) Gel-like composition having high ubiquinol content
JPH09103275A (en) Tablet confection containing galenical extract-compounded microcapsule
JPH0965850A (en) Production of coating powder
CN109414373A (en) Preparation includes the capsule fortreating AIDS of seasoning
CN101119720B (en) Compositions containing polysaccharides
TW202102124A (en) Method for producing emulsified flavoring powder
JP2001152179A (en) Preparation method for powder perfume having persistent flavor
JP3469145B2 (en) Flavored powdered formulation with controlled flavor expression
JP4188512B2 (en) Powder flavor composition and method for producing the same
CN108495644A (en) Removing toxic substances composition for oral use and preparation method thereof
JP3872369B2 (en) Processed honoki leaves and method for producing the same
JP2012115205A (en) Powder flavoring and method for producing the same

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20030107